Healthcare -
Biotechnology - NASDAQ - US
$ 243.34
-1.38 %
$ 31.5 B
Market Cap
-112.14
P/E
ALNY - OPERATING EXPENSES
Operating Expenses ALNY - Alnylam Pharmaceuticals, Inc.
2.1 B
LAST VALUE
12.74%
2 YEAR CAGR
13.13%
5 YEAR CAGR
24.51%
10 YEAR CAGR